HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomohide Tsukahara Selected Research

Aldehyde Dehydrogenase

1/2022High aldehyde dehydrogenase 1 activity is related to radiation resistance due to activation of AKT signaling after insulin stimulation in prostate cancer.
1/2016Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomohide Tsukahara Research Topics

Disease

63Neoplasms (Cancer)
06/2022 - 08/2004
16Sarcoma (Soft Tissue Sarcoma)
02/2021 - 08/2005
14Osteosarcoma (Osteogenic Sarcoma)
10/2020 - 01/2003
8Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2011
7Neoplasm Metastasis (Metastasis)
05/2017 - 01/2013
6Colonic Neoplasms (Colon Cancer)
01/2017 - 06/2011
6Synovial Sarcoma (Synovioma)
09/2012 - 08/2002
5Carcinoma (Carcinomatosis)
02/2021 - 10/2016
5Testicular Neoplasms (Testicular Cancer)
01/2020 - 01/2016
4Lung Neoplasms (Lung Cancer)
01/2017 - 02/2005
3Renal Cell Carcinoma (Grawitz Tumor)
04/2022 - 10/2020
3Carcinogenesis
01/2021 - 01/2017
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2019 - 01/2013
2Microsatellite Instability
01/2022 - 01/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2021 - 01/2017
2Tuberculosis (Tuberculoses)
03/2021 - 01/2021
2Adenocarcinoma of Lung
11/2020 - 01/2013
2Adenocarcinoma
08/2019 - 01/2017
2Hypoxia (Hypoxemia)
12/2016 - 05/2015
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Melena
07/2021
1Massive Hepatic Necrosis
06/2021
1Granuloma
03/2021
1Endometrial Neoplasms (Endometrial Cancer)
03/2021
1Inflammation (Inflammations)
01/2021
1Atopic Dermatitis (Atopic Eczema)
01/2021
1Cystitis
11/2020
1Squamous Cell Carcinoma of Head and Neck
05/2020
1Necrosis
02/2020
1Alveolar Rhabdomyosarcoma
06/2019
1Virus Diseases (Viral Diseases)
01/2019
1Asthma (Bronchial Asthma)
01/2019
1Glioma (Gliomas)
01/2019
1Nausea
10/2018
1Headache (Headaches)
10/2018
1Fatigue
10/2018
1Kidney Neoplasms (Kidney Cancer)
03/2018

Drug/Important Bio-Agent (IBA)

33AntigensIBA
04/2022 - 01/2003
32Peptides (Polypeptides)IBA
04/2022 - 08/2002
10Immune Checkpoint InhibitorsIBA
06/2022 - 01/2016
10Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2007
8HLA-A24 AntigenIBA
10/2020 - 08/2002
6HLA Antigens (Human Leukocyte Antigens)IBA
05/2020 - 02/2008
6SurvivinIBA
02/2020 - 06/2011
6Protein Subunit VaccinesIBA
08/2019 - 02/2005
6HLA-A Antigens (HLA-A)IBA
08/2014 - 12/2002
5Messenger RNA (mRNA)IBA
01/2020 - 01/2009
5EpitopesIBA
04/2019 - 06/2009
4Oxidoreductases (Dehydrogenase)IBA
04/2017 - 05/2015
3Aldehyde Dehydrogenase 1 FamilyIBA
01/2022 - 04/2017
3incomplete Freund's adjuvantIBA
02/2020 - 06/2011
3HLA-B55 antigenIBA
04/2019 - 06/2009
3Histocompatibility Antigens Class IIBA
01/2017 - 05/2015
3HLA-A2 Antigen (HLA A2 Antigen)IBA
08/2014 - 02/2008
3Cancer VaccinesIBA
01/2013 - 04/2009
2Aldehyde DehydrogenaseIBA
01/2022 - 01/2016
2LigandsIBA
11/2021 - 08/2019
2NivolumabIBA
07/2021 - 06/2021
2pembrolizumabIBA
07/2021 - 11/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2021 - 01/2019
2Photosensitizing Agents (Photosensitizers)IBA
02/2021 - 01/2019
2B7-H1 AntigenIBA
11/2020 - 04/2017
2Single-Chain AntibodiesIBA
10/2020 - 08/2014
2GemcitabineFDA Link
08/2019 - 10/2018
2DNA (Deoxyribonucleic Acid)IBA
06/2019 - 08/2012
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019 - 01/2016
2Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2018 - 04/2014
2Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2013
2Monoclonal AntibodiesIBA
08/2014 - 12/2006
2Neoplasm Antigens (Tumor Antigens)IBA
01/2014 - 02/2007
2VaccinesIBA
09/2011 - 04/2009
2Complementary DNA (cDNA)IBA
02/2007 - 08/2004
1CTLA-4 AntigenIBA
04/2022
1Insulin (Novolin)FDA Link
01/2022
1Long Noncoding RNAIBA
11/2021
1IpilimumabIBA
06/2021
1Talaporfin (talaporfin sodium)IBA
02/2021
1Interleukin-13IBA
01/2021
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Interferon-alpha (Interferon Alfa)IBA
02/2020
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2020
1tegafur-gimeracil-oteracilIBA
08/2019
1RNA (Ribonucleic Acid)IBA
06/2019
1Drug CombinationsIBA
06/2019
1Pharmaceutical PreparationsIBA
06/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2019
1AcidsIBA
01/2019
1protoporphyrin IXIBA
01/2019
1TegafurIBA
10/2018
1UracilIBA
10/2018
1Immune Checkpoint ProteinsIBA
04/2017

Therapy/Procedure

35Immunotherapy
06/2022 - 01/2003
24Therapeutics
06/2021 - 02/2007
12Drug Therapy (Chemotherapy)
01/2021 - 08/2004
6Radiotherapy
01/2021 - 01/2013
2Aftercare (After-Treatment)
03/2021 - 01/2013
1Photochemotherapy (Photodynamic Therapy)
02/2021
1Genomic Medicine
06/2019